CAAS Capital Management’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-9,018
| Closed | -$92K | – | 540 |
|
|
2022
Q4 | $92K | Sell |
9,018
-20,753
| -70% | -$212K | 0.01% | 367 |
|
|
2022
Q3 | $783K | Buy |
+29,771
| New | +$783K | 0.04% | 163 |
|
|
2021
Q4 | – | Sell |
-1,249
| Closed | -$169K | – | 702 |
|
|
2021
Q3 | $169K | Sell |
1,249
-7,751
| -86% | -$1.05M | ﹤0.01% | 419 |
|
|
2021
Q2 | $1.32M | Buy |
+9,000
| New | +$1.32M | 0.02% | 211 |
|